Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways

被引：22

作者：

Lynch, Holly Fernandez ^{[1
,2
]}

Bateman-House, Alison ^{[3
]}

机构：

[1] Univ Penn, Med Eth, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA

[3] NYU, Grossman Sch Med, Dept Populat Hlth, New York, NY 10003 USA

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2020年 / 48卷 / 02期

关键词：

US FOOD; DRUGS;

D O I：

10.1177/1073110520935352

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

引用

页码：365 / 372

页数：8

共 41 条

[1]

[Anonymous], 2018, Expanded Access Program Report

[2]

[Anonymous], EM ACC REMD OUTS CLI

[3]

[Anonymous], 2017, New York Times

[4] Conditional approval of medicines by the EMA [J].

Banzi, Rita ;

Gerardi, Chiara ;

Bertele, Vittorio ;

Garattini, Silvio .

BMJ-BRITISH MEDICAL JOURNAL, 2017, 357

[5] A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics A Review [J].

Beaver, Julia A. ;

Howie, Lynn J. ;

Pelosof, Lorraine ;

Kim, Tamy ;

Liu, Jinzhong ;

Goldberg, Kirsten B. ;

Sridhara, Rajeshwari ;

Blumenthal, Gideon M. ;

Farrell, Ann T. ;

Keegan, Patricia ;

Pazdur, Richard ;

Kluetz, Paul G. .

JAMA ONCOLOGY, 2018, 4 (06) :849-856

[6] Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward [J].

Ciani, Oriana ;

Buyse, Marc ;

Drummond, Michael ;

Rasi, Guido ;

Saad, Everardo D. ;

Taylor, Rod S. .

VALUE IN HEALTH, 2017, 20 (03) :487-495

[7]

ClinicalTrials.gov, COVID 19

[8] FDA Approval and Regulation of Pharmaceuticals, 1983-2018 [J].

Darrow, Jonathan J. ;

Avorn, Jerry ;

Kesselheim, Aaron S. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (02) :164-176

[9] Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration [J].

DiMagno, Sarah S. P. ;

Glickman, Aaron ;

Emanuel, Ezekiel J. .

JAMA INTERNAL MEDICINE, 2019, 179 (07) :922-923

[10] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

← 1 2 3 4 5 →